Investment
Features
FeesSafety
Academy
More
Pluang+

Pratt & Whitney completes key F135 engine upgrade review, advancing F-35 Block 4 capabilities.

Market News
15 Sep 2026
PRNewsWire
View Source
Bullish
Pratt & Whitney completes key F135 engine upgrade review, advancing F-35 Block 4 capabilities.

Pratt & Whitney has successfully completed the Risk Reduction Design Review for the F135 Engine Core Upgrade, a critical step validating the engine's design maturity and readiness for production. This upgrade enhances power and thermal management to support advanced sensors and weapons for all F-35 variants, enabling Block 4 and future capabilities. The program is on track to improve fleet readiness and provide a cost-effective modernization path, with the upgrade designed as a drop-in solution for new and existing aircraft. Pratt & Whitney continues to support a global F-35 fleet with over 1,500 engines delivered to 20 allied nations.

Pratt & Whitney's F135 Engine Core Upgrade is the subject, with this Pluang market snapshot for Industrials-sector US stocks as of Sep 15, 2026 16:51 WIB: Of 75 stocks, only 17 rose while 52 fell. Notably, TECK was priced at USD 63.98 with a 1-day change of -3.43%, contrasting with SBLK at USD 29.99 down 2.72%, and EH at USD 4.42 down 2.00%.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App